Behcet's disease in children [2] (multiple letters)

Journal of Pediatrics

Volumn 134, Issue 2, 1999, Pages 249-251

  Yasui, K ^a   Komiyama, A ^a   Takabayashi, Y ^a   Fujikawa, S ^a   Kone Paut, I ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; PENTOXIFYLLINE; ENZYME INHIBITOR;

BEHCET DISEASE; CLINICAL FEATURE; DRUG EFFICACY; GENETIC SUSCEPTIBILITY; HUMAN; LETTER; LEUKOCYTE FUNCTION; NEUTROPHIL; PRIORITY JOURNAL; CHILD; NOTE;

BEHCET SYNDROME; CHILD; ENZYME INHIBITORS; HUMANS; PENTOXIFYLLINE;

EID: 0033069812     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-3476(99)70431-2     Document Type: Letter

References (7)

1. I Koné-Paut S Yurdakul SA Bahabri N Shafae S Ozen H Özdogan Clinical features of BehBehÁetís ccedil;etBehÁetís rsquo;s disease in children: an international collaborative study of 86 cases J Pediatr 132 1998 721 725
2. International Study Group for Behçet’s Disease Criteria for diagnosis of Behçet’s disease Lancet 335 1990 1078 1080
3. K Yasui K Ohta M Kobayashi T Aizawa A. Komiyama Successful treatment of Behçet’s disease with pentoxifylline Ann Intern Med 124 1996 891 893
4. H Imai M Motegi N Mizuki H Ohtani A Komatsuda K Hanai Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome): A case report and literature review Am J Med Sci 314 1997 330 332
5. T Chajek-Shaul S Pisanty H Knobler Y Matzner M Glick N Ron HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet’s syndrome Am J Med 83 1987 666 672
6. HR Hill NH Augustine JA Newton AO Shigeoka E Morris F. Sacchi Correction of a developmental defect in neutrophil activation and movement Am J Pathol 128 1987 307 314
7. K Yasui A Komiyama TFP Molski RI. Sha’afi Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions Infect Immun 62 1994 922 927